Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиRocket Pharmaceuticals Мультипликаторы 2011-2024 | RCKT
Мультипликаторы по годам Rocket Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-10.6 | -5.9 | -6.2 | -21.8 | -14.0 | -7.4 | -4.0 | -1.0 | -2.1 | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-2.9 | -3.3 | -2.7 | -2.5 | -1.6 | -1.9 | -2.9 | -1.1 | -3.7 | -13.5 | - | - | - |
EV (Enterprise Value) |
2.62 млрд | 1.23 млрд | 860 млн | 2.84 млрд | 958 млн | 494 млн | 92.2 млн | 68.1 млн | 67.8 млн | 6.66 млн | 10.5 млн | 3.79 млн | - |
EBITDA per Share |
-3.03 | -3.23 | -2.59 | -2.43 | -1.55 | -1.8 | -3.92 | -6.24 | -4.45 | - | - | - | - |
EV/EBITDA |
-4.9 | -20.9 | -12.4 | -6.8 | -3.3 | -1.5 | -3.1 | - | - | - | - | ||
PEG |
-0.78 | -1.45 | 0.75 | 14.11 | -0.85 | -0.13 | -0.12 | -0.02 | 0.0 | - | - | - | - |
P/B |
5.3 | 2.7 | 2.3 | 6.1 | 3.5 | 2.8 | 2.4 | 0.6 | 1.3 | - | - | - | - |
P/CF |
-13.3 | -7.3 | -8.7 | -40.9 | -12.3 | -9.9 | -4.5 | -1.1 | -8.0 | - | - | - | - |
ROE % |
-49.86 | -45.31 | -37.18 | -27.74 | -25.15 | -38.40 | -61.76 | -58.57 | -62.48 | - | - | - | - |
ROA % |
-43.37 | -40.21 | -34.02 | -23.64 | -20.76 | -29.65 | -28.98 | -33.05 | -59.99 | - | - | - | - |
ROCE % |
-52.71 | -45.81 | -36.78 | -26.67 | -21.52 | -30.16 | -27.36 | -34.21 | -18.68 | - | - | - | - |
Current Ratio |
7.7 | 8.9 | 11.8 | 6.8 | 16.8 | 13.6 | 24.8 | 17.8 | 27.1 | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Rocket Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.75 | -0.82 | -0.73 | - | -0.87 | -0.83 | -0.67 | - | -0.79 | -0.55 | -0.65 | -1.09 | -0.53 | -0.45 | -0.45 | -0.39 | -0.38 | -0.38 | -0.43 | -0.66 | -0.4 | -0.4 | -0.42 | -0.98 | -0.99 | -0.49 | -0.39 | - | -0.41 | -0.33 | -0.38 | - | -2.48 | -0.15 | -0.21 | - | -3.42 | -3.81 | -3.08 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | -0.88 | -0.83 | -0.66 | - | -0.77 | -0.53 | -0.63 | -0.97 | -0.49 | -0.43 | -0.44 | -0.36 | -0.38 | -0.37 | -0.42 | -0.59 | -0.38 | -0.37 | -0.4 | -0.98 | -0.98 | -0.51 | -0.42 | - | -0.4 | -0.33 | -0.38 | - | -0.24 | -0.23 | -0.4 | - | -2.04 | -2.15 | -1.68 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-56.18 | -60.46 | -58.19 | -40.05 | -50.37 | -44.96 | -37.99 | -25.74 | -37.84 | -33.30 | -31.22 | -27.74 | -22.11 | -22.61 | -23.71 | -25.15 | -32.76 | -34.78 | -36.83 | -38.40 | -67.21 | -102.24 | -116.80 | -126.16 | -98.48 | -70.37 | -59.55 | -40.84 | -92.27 | -128.49 | -118.81 | -54.97 | -50.33 | 5.73 | 13.44 | 14.32 | 14.32 | 9.69 | 4.17 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-49.74 | -53.24 | -51.61 | -35.78 | -45.23 | -40.84 | -34.70 | -22.87 | -33.18 | -28.65 | -26.44 | -23.64 | -18.67 | -18.93 | -19.71 | -20.76 | -26.30 | -27.52 | -28.77 | -29.65 | -51.81 | -78.78 | -89.98 | -97.18 | -72.73 | -47.94 | -37.16 | -23.05 | -72.43 | -113.23 | -108.64 | -52.78 | -96.04 | -89.92 | -139.39 | -133.75 | -133.75 | -90.49 | -38.91 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-58.63 | -62.46 | -59.38 | -40.10 | -50.32 | -44.62 | -37.59 | -25.35 | -37.11 | -32.33 | -30.05 | -26.67 | -21.30 | -22.10 | -23.41 | -24.78 | -32.07 | -33.73 | -35.41 | -36.67 | -65.88 | -101.31 | -116.34 | -127.41 | -99.17 | -70.49 | -59.80 | -40.51 | -45.51 | -35.85 | -27.23 | -11.18 | -7.14 | 1.91 | 9.54 | 11.62 | 11.62 | 7.58 | 3.32 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
10.4 | 7.8 | 9.2 | 8.9 | 8.3 | 9.8 | 10.8 | 11.8 | 11.9 | 11.7 | 6.0 | 6.8 | 6.8 | 6.8 | 6.8 | 5.7 | 5.7 | 5.7 | 5.7 | 4.4 | 4.4 | 4.4 | 4.4 | 4.3 | 4.3 | 4.3 | 4.3 | 2.3 | 2.3 | 2.3 | 2.3 | 25.1 | 25.1 | 25.1 | 25.1 | 0.5 | 0.5 | 0.5 | 0.5 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD